Neogen (NEOG) Asset Writedowns and Impairment (2023 - 2025)

Neogen's Asset Writedowns and Impairment history runs 3 years deep, the most recent figure standing at $597.9 million for Q2 2025.

• In Q2 2025, Asset Writedowns and Impairment rose 99550.0% year-over-year to $597.9 million; the TTM figure through May 2026 stood at $600.0 million (changed 0.02% YoY), while the FY2025 annual figure was $1.1 billion, up 178016.67% from the prior year.
• Asset Writedowns and Impairment for Q2 2025 stood at $597.9 million, up from $2.1 million in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $597.9 million in Q2 2025, with the low at -$716000.0 in Q1 2024.
• The 3-year median for Asset Writedowns and Impairment is $809000.0 (2023), against an average of $120.1 million.
• The sharpest annual moves came in 2024 and 2025: Asset Writedowns and Impairment fell 25.83% in 2024, then soared 99550.0% in 2025.
• Neogen's Asset Writedowns and Impairment stood at $809000.0 in 2023, then decreased by 25.83% to $600000.0 in 2024, then jumped by 99550.0% to $597.9 million in 2025.
• Business Quant data shows NEOG's Asset Writedowns and Impairment at $597.9 million in Q2 2025, $2.1 million in Q1 2025, and $600000.0 in Q2 2024.